Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2023-04-25 AGM Information
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
普莱柯关于召开2022年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2022 Annual General Meeting (AGM) of the company 普莱柯生物工程股份有限公司. It includes details such as the date and time of the meeting, voting methods, agenda items to be discussed and voted on (including the 2022 annual report, board reports, financial statements, profit distribution, auditor appointment, and remuneration), and instructions for shareholders on how to attend and vote. The document does not contain the actual annual report or financial statements but rather serves as an announcement and invitation to the AGM. The document length is 3641 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2023-04-25 Chinese
普莱柯2022年度内部控制审计报告
Regulatory Filings
2023-04-25 Chinese
普莱柯第五届董事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of the resolutions passed at the first meeting of the fifth board of directors of the company. It details the election of the chairman, vice chairman, appointment of senior management including general manager, deputy general managers, financial director, and board secretary. It also includes voting results and mentions compliance with company law and articles of association. There is no financial data or report content, only management and board changes. This fits the category of Board/Management Information (MANG). The document length is short and it is clearly an announcement of board and management appointments, not a full report or financial statement.
2023-04-11 Chinese
北京德恒律师事务所关于普莱柯生物工程股份有限公司2023年第一次临时股东大会的法律意见
Regulatory Filings Classification · 90% confidence The document text contains only placeholders indicating omitted pictures and no actual textual content or financial data. The total character count is 979, which is very short and does not contain any substantive information or report content. There is no indication of report type, fiscal period, regulatory references, or any other clues to classify it as a specific report. Given the lack of content and the presence of only images (omitted), this document is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2023-04-11 Chinese
普莱柯2023年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2023 first extraordinary general meeting of shareholders of 普莱柯生物工程股份有限公司. It details the meeting date, attendance, voting results for board and supervisory board elections, and legal compliance statements. The content focuses on the voting outcomes and official confirmation of the meeting's validity. It does not contain financial statements or detailed financial analysis, nor is it a presentation or a report publication notice. The document is clearly an official declaration of voting results from a shareholders' meeting, matching the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2671 characters, which is consistent with a voting results announcement rather than a full report.
2023-04-11 Chinese
普莱柯关于选举职工代表监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of an employee representative supervisor to the company's supervisory board. It includes details about the election process, the term of the new supervisor, and a brief resume of the elected individual. There is no financial data, no mention of financial results, no regulatory certifications, or report publications. The content focuses on board/management changes, specifically the election of a supervisory board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2023-04-11 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.